WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Zydus Lifesciences' Rs 1,100 crore share buyback at 13% premium: Check record date, other details

Zydus Lifesciences is launching its largest share buyback program to date. The company plans to repurchase shares worth Rs 1,100 crore. This move offers shareholders a premium price. The record date for eligibility is May 29. The buyback will be conducted through a tender route. This follows previous successful buyback initiatives by the company.

Raccontata dathehindubusinessline.comeconomictimes.indiatimes.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
economictimes.indiatimes.comStai leggendo1 mesi fa

Zydus Lifesciences' Rs 1,100 crore share buyback at 13% premium: Check record date, other details

Zydus Lifesciences is launching its largest share buyback program to date. The company plans to repurchase shares worth Rs 1,100 crore. This move offers shareholders a premium price. The record date for eligibility is…

originale
thehindubusinessline.com1 mesi fa

Zydus Lifesciences Q4 profit rises 8.7% to ₹1,272 crore; announces ₹1,100 crore buyback

Zydus Lifesciences Limited reported an 8.7% year-on-year increase in consolidated net profit that stood at ₹1,272 crore for the quarter ended March 2026, impacted by a one-time expense related to the Mirabegron…

Timeline cronologica

  1. martedì 19 maggio 2026·thehindubusinessline.com

    Zydus Lifesciences Q4 profit rises 8.7% to ₹1,272 crore; announces ₹1,100 crore buyback

    Zydus Lifesciences Limited reported an 8.7% year-on-year increase in consolidated net profit that stood at ₹1,272 crore for the quarter ended March 2026, impacted by a one-time…

  2. mercoledì 20 maggio 2026·economictimes.indiatimes.com

    Zydus Lifesciences' Rs 1,100 crore share buyback at 13% premium: Check record date, other details

    Zydus Lifesciences is launching its largest share buyback program to date. The company plans to repurchase shares worth Rs 1,100 crore. This move offers shareholders a premium…

Leggi questa versione → originale
  • mercoledì 20 maggio 2026·economictimes.indiatimes.com

    Zydus Lifesciences shares soar 7% to fresh record high after Q4 results. Should you buy, sell or hold?

    Zydus Lifesciences shares climbed to a new 52-week high. The company reported a 9% rise in net profit and over 16% revenue growth for the January-March quarter. A Rs 1,100 crore…